Global Blood Plasma Fractionation Market Growth 2024-2030
Blood Plasma Fractionation market expands from US$27.70 billion in 2023 to US$47.22 billion by 2030, with a 7.9% CAGR, driven by increasing demand in the downstream market.
- Bonafide Trust
- 04-01-2024
- Pages : 137
- Figures : 83
- Tables : 169
- Region : Global
- Category : Lifescience
- Medical Devices
Blood plasma, the straw-colored liquid component that makes up about 55% of whole blood volume, is a treasure trove of life-saving proteins. These proteins orchestrate a vast array of critical functions within the body, from transporting nutrients and hormones to regulating fluid balance and immunological defense. The global blood plasma fractionation market focuses on extracting these valuable components from donated plasma, transforming them into life-saving treatments for a multitude of conditions. This intricate process, known as fractionation, separates plasma into its constituent proteins, each with unique therapeutic properties.
According to our latest study, the global Blood Plasma Fractionation market size was valued at US$ 27700 million in 2023. With growing demand in downstream market, the Blood Plasma Fractionation is forecast to a readjusted size of US$ 47220 million by 2030 with a CAGR of 7.9% during review period.
The research report highlights the growth potential of the global Blood Plasma Fractionation market. Blood Plasma Fractionation are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Blood Plasma Fractionation. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Blood Plasma Fractionation market.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleHuman blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation.
Global key blood plasma fractionation players include CSL, Grifols and Takeda etc. The top 3 companies hold a share about 55%. North America is the largest market with a share about 40%, followed by Asia-Pacific and Europe.
In terms of product, Immune Globulin is the largest segment with a share about 50%. And in terms of applications, the largest application is hospital with a share about 70%.
Key Features:
The report on Blood Plasma Fractionation market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Blood Plasma Fractionation market. It may include historical data, market segmentation by Type (e.g., Immune Globulin, Coagulation Factor), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Blood Plasma Fractionation market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Blood Plasma Fractionation Market Dynamics: A Balancing Act
The global blood plasma fractionation market is a vital source of life-saving treatments, but navigating its dynamics requires a keen understanding of both its drivers and challenges.
Market Drivers:
• Rising Demand: Chronic diseases like immunodeficiencies and hemophilia are on the rise, fueling demand for plasma-derived therapies.
• Aging Population: As populations age, the need for these treatments for age-related conditions like weakened immunity grows.
Market Trends:
• Technological Advancements: New fractionation techniques are improving the yield and purity of plasma products, enhancing their effectiveness.
• Emerging Market Focus: Developing economies with growing healthcare infrastructure are presenting new opportunities for plasma collection and fractionation.
Market Challenges:
• Plasma Shortage: Donor recruitment and retention programs are crucial as global demand for plasma often outpaces supply, especially in developing regions.
• Cost Concerns: The high cost of developing, manufacturing, and storing plasma-derived therapies can limit access for some patients.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Blood Plasma Fractionation market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Blood Plasma Fractionation industry. This include advancements in Blood Plasma Fractionation technology, Blood Plasma Fractionation new entrants, Blood Plasma Fractionation new investment, and other innovations that are shaping the future of Blood Plasma Fractionation.
• Precision Fractionation: Advanced techniques are isolating plasma proteins with greater purity and specificity, leading to more targeted and effective therapies.
• Automated Systems: Streamlined plasma collection and processing through automation boosts efficiency and reduces contamination risks.
• Yield Optimization: Innovations in fractionation processes are increasing the yield of valuable plasma proteins, maximizing the use of this precious resource.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Blood Plasma Fractionation market. It includes factors influencing customer ' purchasing decisions, preferences for Blood Plasma Fractionation product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Blood Plasma Fractionation market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Blood Plasma Fractionation market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Blood Plasma Fractionation market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Blood Plasma Fractionation industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
• Chronic Disease Burden: Rising prevalence of conditions like immunodeficiencies and hemophilia fuels demand for these specialized treatments.
• Aging Advantage: An aging population creates a need for plasma-derived therapies for age-related conditions affecting the immune system.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Blood Plasma Fractionation market.
• Boosting Plasma Supply: Implement effective donor recruitment and retention programs to address the global plasma shortage.
• Innovation Drive: Invest in research and development of novel plasma collection technologies and explore new therapeutic applications for plasma proteins.
Market Segmentation:
Blood Plasma Fractionation market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Immune Globulin
Coagulation Factor
Albumin
Other
Segmentation by application
Hospital
Retail Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Blood Plasma Fractionation Annual Sales 2019-2030
- 2.1.2 World Current & Future Analysis for Blood Plasma Fractionation by Geographic Region, 2019, 2023 & 2030
- 2.1.3 World Current & Future Analysis for Blood Plasma Fractionation by Country/Region, 2019, 2023 & 2030
- 2.2 Blood Plasma Fractionation Segment by Type
- 2.2.1 Immune Globulin
- 2.2.2 Coagulation Factor
- 2.2.3 Albumin
- 2.2.4 Other
- 2.3 Blood Plasma Fractionation Sales by Type
- 2.3.1 Global Blood Plasma Fractionation Sales Market Share by Type (2019-2024)
- 2.3.2 Global Blood Plasma Fractionation Revenue and Market Share by Type (2019-2024)
- 2.3.3 Global Blood Plasma Fractionation Sale Price by Type (2019-2024)
- 2.4 Blood Plasma Fractionation Segment by Application
- 2.4.1 Hospital
- 2.4.2 Retail Pharmacy
- 2.4.3 Other
- 2.5 Blood Plasma Fractionation Sales by Application
- 2.5.1 Global Blood Plasma Fractionation Sale Market Share by Application (2019-2024)
- 2.5.2 Global Blood Plasma Fractionation Revenue and Market Share by Application (2019-2024)
- 2.5.3 Global Blood Plasma Fractionation Sale Price by Application (2019-2024)
- 3 Global Blood Plasma Fractionation by Company
- 3.1 Global Blood Plasma Fractionation Breakdown Data by Company
- 3.1.1 Global Blood Plasma Fractionation Annual Sales by Company (2019-2024)
- 3.1.2 Global Blood Plasma Fractionation Sales Market Share by Company (2019-2024)
- 3.2 Global Blood Plasma Fractionation Annual Revenue by Company (2019-2024)
- 3.2.1 Global Blood Plasma Fractionation Revenue by Company (2019-2024)
- 3.2.2 Global Blood Plasma Fractionation Revenue Market Share by Company (2019-2024)
- 3.3 Global Blood Plasma Fractionation Sale Price by Company
- 3.4 Key Manufacturers Blood Plasma Fractionation Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Blood Plasma Fractionation Product Location Distribution
- 3.4.2 Players Blood Plasma Fractionation Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
- 4 World Historic Review for Blood Plasma Fractionation by Geographic Region
- 4.1 World Historic Blood Plasma Fractionation Market Size by Geographic Region (2019-2024)
- 4.1.1 Global Blood Plasma Fractionation Annual Sales by Geographic Region (2019-2024)
- 4.1.2 Global Blood Plasma Fractionation Annual Revenue by Geographic Region (2019-2024)
- 4.2 World Historic Blood Plasma Fractionation Market Size by Country/Region (2019-2024)
- 4.2.1 Global Blood Plasma Fractionation Annual Sales by Country/Region (2019-2024)
- 4.2.2 Global Blood Plasma Fractionation Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas Blood Plasma Fractionation Sales Growth
- 4.4 APAC Blood Plasma Fractionation Sales Growth
- 4.5 Europe Blood Plasma Fractionation Sales Growth
- 4.6 Middle East & Africa Blood Plasma Fractionation Sales Growth
- 5 Americas
- 5.1 Americas Blood Plasma Fractionation Sales by Country
- 5.1.1 Americas Blood Plasma Fractionation Sales by Country (2019-2024)
- 5.1.2 Americas Blood Plasma Fractionation Revenue by Country (2019-2024)
- 5.2 Americas Blood Plasma Fractionation Sales by Type
- 5.3 Americas Blood Plasma Fractionation Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Blood Plasma Fractionation Sales by Region
- 6.1.1 APAC Blood Plasma Fractionation Sales by Region (2019-2024)
- 6.1.2 APAC Blood Plasma Fractionation Revenue by Region (2019-2024)
- 6.2 APAC Blood Plasma Fractionation Sales by Type
- 6.3 APAC Blood Plasma Fractionation Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
- 7 Europe
- 7.1 Europe Blood Plasma Fractionation by Country
- 7.1.1 Europe Blood Plasma Fractionation Sales by Country (2019-2024)
- 7.1.2 Europe Blood Plasma Fractionation Revenue by Country (2019-2024)
- 7.2 Europe Blood Plasma Fractionation Sales by Type
- 7.3 Europe Blood Plasma Fractionation Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Blood Plasma Fractionation by Country
- 8.1.1 Middle East & Africa Blood Plasma Fractionation Sales by Country (2019-2024)
- 8.1.2 Middle East & Africa Blood Plasma Fractionation Revenue by Country (2019-2024)
- 8.2 Middle East & Africa Blood Plasma Fractionation Sales by Type
- 8.3 Middle East & Africa Blood Plasma Fractionation Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Blood Plasma Fractionation
- 10.3 Manufacturing Process Analysis of Blood Plasma Fractionation
- 10.4 Industry Chain Structure of Blood Plasma Fractionation
- 11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Blood Plasma Fractionation Distributors
- 11.3 Blood Plasma Fractionation Customer
- 12 World Forecast Review for Blood Plasma Fractionation by Geographic Region
- 12.1 Global Blood Plasma Fractionation Market Size Forecast by Region
- 12.1.1 Global Blood Plasma Fractionation Forecast by Region (2025-2030)
- 12.1.2 Global Blood Plasma Fractionation Annual Revenue Forecast by Region (2025-2030)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Blood Plasma Fractionation Forecast by Type
- 12.7 Global Blood Plasma Fractionation Forecast by Application
- 13 Key Players Analysis
- 13.1 Takeda
- 13.1.1 Takeda Company Information
- 13.1.2 Takeda Blood Plasma Fractionation Product Portfolios and Specifications
- 13.1.3 Takeda Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.1.4 Takeda Main Business Overview
- 13.1.5 Takeda Latest Developments
- 13.2 CSL
- 13.2.1 CSL Company Information
- 13.2.2 CSL Blood Plasma Fractionation Product Portfolios and Specifications
- 13.2.3 CSL Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.2.4 CSL Main Business Overview
- 13.2.5 CSL Latest Developments
- 13.3 Grifols
- 13.3.1 Grifols Company Information
- 13.3.2 Grifols Blood Plasma Fractionation Product Portfolios and Specifications
- 13.3.3 Grifols Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.3.4 Grifols Main Business Overview
- 13.3.5 Grifols Latest Developments
- 13.4 Octapharma
- 13.4.1 Octapharma Company Information
- 13.4.2 Octapharma Blood Plasma Fractionation Product Portfolios and Specifications
- 13.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.4.4 Octapharma Main Business Overview
- 13.4.5 Octapharma Latest Developments
- 13.5 Kedrion
- 13.5.1 Kedrion Company Information
- 13.5.2 Kedrion Blood Plasma Fractionation Product Portfolios and Specifications
- 13.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.5.4 Kedrion Main Business Overview
- 13.5.5 Kedrion Latest Developments
- 13.6 LFB Group
- 13.6.1 LFB Group Company Information
- 13.6.2 LFB Group Blood Plasma Fractionation Product Portfolios and Specifications
- 13.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.6.4 LFB Group Main Business Overview
- 13.6.5 LFB Group Latest Developments
- 13.7 Biotest
- 13.7.1 Biotest Company Information
- 13.7.2 Biotest Blood Plasma Fractionation Product Portfolios and Specifications
- 13.7.3 Biotest Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.7.4 Biotest Main Business Overview
- 13.7.5 Biotest Latest Developments
- 13.8 BPL
- 13.8.1 BPL Company Information
- 13.8.2 BPL Blood Plasma Fractionation Product Portfolios and Specifications
- 13.8.3 BPL Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.8.4 BPL Main Business Overview
- 13.8.5 BPL Latest Developments
- 13.9 RAAS
- 13.9.1 RAAS Company Information
- 13.9.2 RAAS Blood Plasma Fractionation Product Portfolios and Specifications
- 13.9.3 RAAS Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.9.4 RAAS Main Business Overview
- 13.9.5 RAAS Latest Developments
- 13.10 CBPO
- 13.10.1 CBPO Company Information
- 13.10.2 CBPO Blood Plasma Fractionation Product Portfolios and Specifications
- 13.10.3 CBPO Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.10.4 CBPO Main Business Overview
- 13.10.5 CBPO Latest Developments
- 13.11 Hualan Bio
- 13.11.1 Hualan Bio Company Information
- 13.11.2 Hualan Bio Blood Plasma Fractionation Product Portfolios and Specifications
- 13.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.11.4 Hualan Bio Main Business Overview
- 13.11.5 Hualan Bio Latest Developments
- 13.12 Tiantan Bio
- 13.12.1 Tiantan Bio Company Information
- 13.12.2 Tiantan Bio Blood Plasma Fractionation Product Portfolios and Specifications
- 13.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.12.4 Tiantan Bio Main Business Overview
- 13.12.5 Tiantan Bio Latest Developments
- 13.13 Shuanglin Bio
- 13.13.1 Shuanglin Bio Company Information
- 13.13.2 Shuanglin Bio Blood Plasma Fractionation Product Portfolios and Specifications
- 13.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.13.4 Shuanglin Bio Main Business Overview
- 13.13.5 Shuanglin Bio Latest Developments
- 13.14 Boya Bio
- 13.14.1 Boya Bio Company Information
- 13.14.2 Boya Bio Blood Plasma Fractionation Product Portfolios and Specifications
- 13.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.14.4 Boya Bio Main Business Overview
- 13.14.5 Boya Bio Latest Developments
- 13.15 Yuanda Shuyang
- 13.15.1 Yuanda Shuyang Company Information
- 13.15.2 Yuanda Shuyang Blood Plasma Fractionation Product Portfolios and Specifications
- 13.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.15.4 Yuanda Shuyang Main Business Overview
- 13.15.5 Yuanda Shuyang Latest Developments
- 13.16 Weiguang Bio
- 13.16.1 Weiguang Bio Company Information
- 13.16.2 Weiguang Bio Blood Plasma Fractionation Product Portfolios and Specifications
- 13.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.16.4 Weiguang Bio Main Business Overview
- 13.16.5 Weiguang Bio Latest Developments
- 13.17 Nanyue Bio
- 13.17.1 Nanyue Bio Company Information
- 13.17.2 Nanyue Bio Blood Plasma Fractionation Product Portfolios and Specifications
- 13.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.17.4 Nanyue Bio Main Business Overview
- 13.17.5 Nanyue Bio Latest Developments
- 13.18 KM Biologics
- 13.18.1 KM Biologics Company Information
- 13.18.2 KM Biologics Blood Plasma Fractionation Product Portfolios and Specifications
- 13.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.18.4 KM Biologics Main Business Overview
- 13.18.5 KM Biologics Latest Developments
- 14 Research Findings and Conclusion
List of Tables
Table 1. Blood Plasma Fractionation Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Blood Plasma Fractionation Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Immune Globulin
Table 4. Major Players of Coagulation Factor
Table 5. Major Players of Albumin
Table 6. Major Players of Other
Table 7. Global Blood Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 8. Global Blood Plasma Fractionation Sales Market Share by Type (2019-2024)
Table 9. Global Blood Plasma Fractionation Revenue by Type (2019-2024) & ($ million)
Table 10. Global Blood Plasma Fractionation Revenue Market Share by Type (2019-2024)
Table 11. Global Blood Plasma Fractionation Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Blood Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 13. Global Blood Plasma Fractionation Sales Market Share by Application (2019-2024)
Table 14. Global Blood Plasma Fractionation Revenue by Application (2019-2024)
Table 15. Global Blood Plasma Fractionation Revenue Market Share by Application (2019-2024)
Table 16. Global Blood Plasma Fractionation Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Blood Plasma Fractionation Sales by Company (2019-2024) & (K Units)
Table 18. Global Blood Plasma Fractionation Sales Market Share by Company (2019-2024)
Table 19. Global Blood Plasma Fractionation Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Blood Plasma Fractionation Revenue Market Share by Company (2019-2024)
Table 21. Global Blood Plasma Fractionation Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Blood Plasma Fractionation Producing Area Distribution and Sales Area
Table 23. Players Blood Plasma Fractionation Products Offered
Table 24. Blood Plasma Fractionation Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Blood Plasma Fractionation Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Blood Plasma Fractionation Sales Market Share Geographic Region (2019-2024)
Table 29. Global Blood Plasma Fractionation Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Blood Plasma Fractionation Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Blood Plasma Fractionation Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Blood Plasma Fractionation Sales Market Share by Country/Region (2019-2024)
Table 33. Global Blood Plasma Fractionation Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Blood Plasma Fractionation Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Blood Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 36. Americas Blood Plasma Fractionation Sales Market Share by Country (2019-2024)
Table 37. Americas Blood Plasma Fractionation Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Blood Plasma Fractionation Revenue Market Share by Country (2019-2024)
Table 39. Americas Blood Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 40. Americas Blood Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 41. APAC Blood Plasma Fractionation Sales by Region (2019-2024) & (K Units)
Table 42. APAC Blood Plasma Fractionation Sales Market Share by Region (2019-2024)
Table 43. APAC Blood Plasma Fractionation Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Blood Plasma Fractionation Revenue Market Share by Region (2019-2024)
Table 45. APAC Blood Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 46. APAC Blood Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 47. Europe Blood Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 48. Europe Blood Plasma Fractionation Sales Market Share by Country (2019-2024)
Table 49. Europe Blood Plasma Fractionation Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Blood Plasma Fractionation Revenue Market Share by Country (2019-2024)
Table 51. Europe Blood Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 52. Europe Blood Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Blood Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Blood Plasma Fractionation Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Blood Plasma Fractionation Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Blood Plasma Fractionation Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Blood Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Blood Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Blood Plasma Fractionation
Table 60. Key Market Challenges & Risks of Blood Plasma Fractionation
Table 61. Key Industry Trends of Blood Plasma Fractionation
Table 62. Blood Plasma Fractionation Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Blood Plasma Fractionation Distributors List
Table 65. Blood Plasma Fractionation Customer List
Table 66. Global Blood Plasma Fractionation Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Blood Plasma Fractionation Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Blood Plasma Fractionation Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Blood Plasma Fractionation Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Blood Plasma Fractionation Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Blood Plasma Fractionation Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Blood Plasma Fractionation Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Blood Plasma Fractionation Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Blood Plasma Fractionation Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Blood Plasma Fractionation Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Blood Plasma Fractionation Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Blood Plasma Fractionation Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Blood Plasma Fractionation Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Blood Plasma Fractionation Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Takeda Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 81. Takeda Blood Plasma Fractionation Product Portfolios and Specifications
Table 82. Takeda Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Takeda Main Business
Table 84. Takeda Latest Developments
Table 85. CSL Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 86. CSL Blood Plasma Fractionation Product Portfolios and Specifications
Table 87. CSL Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. CSL Main Business
Table 89. CSL Latest Developments
Table 90. Grifols Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 91. Grifols Blood Plasma Fractionation Product Portfolios and Specifications
Table 92. Grifols Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Grifols Main Business
Table 94. Grifols Latest Developments
Table 95. Octapharma Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 96. Octapharma Blood Plasma Fractionation Product Portfolios and Specifications
Table 97. Octapharma Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Octapharma Main Business
Table 99. Octapharma Latest Developments
Table 100. Kedrion Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 101. Kedrion Blood Plasma Fractionation Product Portfolios and Specifications
Table 102. Kedrion Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Kedrion Main Business
Table 104. Kedrion Latest Developments
Table 105. LFB Group Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 106. LFB Group Blood Plasma Fractionation Product Portfolios and Specifications
Table 107. LFB Group Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. LFB Group Main Business
Table 109. LFB Group Latest Developments
Table 110. Biotest Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 111. Biotest Blood Plasma Fractionation Product Portfolios and Specifications
Table 112. Biotest Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Biotest Main Business
Table 114. Biotest Latest Developments
Table 115. BPL Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 116. BPL Blood Plasma Fractionation Product Portfolios and Specifications
Table 117. BPL Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. BPL Main Business
Table 119. BPL Latest Developments
Table 120. RAAS Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 121. RAAS Blood Plasma Fractionation Product Portfolios and Specifications
Table 122. RAAS Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. RAAS Main Business
Table 124. RAAS Latest Developments
Table 125. CBPO Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 126. CBPO Blood Plasma Fractionation Product Portfolios and Specifications
Table 127. CBPO Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. CBPO Main Business
Table 129. CBPO Latest Developments
Table 130. Hualan Bio Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Bio Blood Plasma Fractionation Product Portfolios and Specifications
Table 132. Hualan Bio Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Hualan Bio Main Business
Table 134. Hualan Bio Latest Developments
Table 135. Tiantan Bio Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 136. Tiantan Bio Blood Plasma Fractionation Product Portfolios and Specifications
Table 137. Tiantan Bio Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Tiantan Bio Main Business
Table 139. Tiantan Bio Latest Developments
Table 140. Shuanglin Bio Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 141. Shuanglin Bio Blood Plasma Fractionation Product Portfolios and Specifications
Table 142. Shuanglin Bio Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Shuanglin Bio Main Business
Table 144. Shuanglin Bio Latest Developments
Table 145. Boya Bio Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 146. Boya Bio Blood Plasma Fractionation Product Portfolios and Specifications
Table 147. Boya Bio Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Boya Bio Main Business
Table 149. Boya Bio Latest Developments
Table 150. Yuanda Shuyang Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 151. Yuanda Shuyang Blood Plasma Fractionation Product Portfolios and Specifications
Table 152. Yuanda Shuyang Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Yuanda Shuyang Main Business
Table 154. Yuanda Shuyang Latest Developments
Table 155. Weiguang Bio Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 156. Weiguang Bio Blood Plasma Fractionation Product Portfolios and Specifications
Table 157. Weiguang Bio Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Weiguang Bio Main Business
Table 159. Weiguang Bio Latest Developments
Table 160. Nanyue Bio Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 161. Nanyue Bio Blood Plasma Fractionation Product Portfolios and Specifications
Table 162. Nanyue Bio Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Nanyue Bio Main Business
Table 164. Nanyue Bio Latest Developments
Table 165. KM Biologics Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 166. KM Biologics Blood Plasma Fractionation Product Portfolios and Specifications
Table 167. KM Biologics Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. KM Biologics Main Business
Table 169. KM Biologics Latest Developments
Table 1. Blood Plasma Fractionation Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Blood Plasma Fractionation Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Immune Globulin
Table 4. Major Players of Coagulation Factor
Table 5. Major Players of Albumin
Table 6. Major Players of Other
Table 7. Global Blood Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 8. Global Blood Plasma Fractionation Sales Market Share by Type (2019-2024)
Table 9. Global Blood Plasma Fractionation Revenue by Type (2019-2024) & ($ million)
Table 10. Global Blood Plasma Fractionation Revenue Market Share by Type (2019-2024)
Table 11. Global Blood Plasma Fractionation Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Blood Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 13. Global Blood Plasma Fractionation Sales Market Share by Application (2019-2024)
Table 14. Global Blood Plasma Fractionation Revenue by Application (2019-2024)
Table 15. Global Blood Plasma Fractionation Revenue Market Share by Application (2019-2024)
Table 16. Global Blood Plasma Fractionation Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Blood Plasma Fractionation Sales by Company (2019-2024) & (K Units)
Table 18. Global Blood Plasma Fractionation Sales Market Share by Company (2019-2024)
Table 19. Global Blood Plasma Fractionation Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Blood Plasma Fractionation Revenue Market Share by Company (2019-2024)
Table 21. Global Blood Plasma Fractionation Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Blood Plasma Fractionation Producing Area Distribution and Sales Area
Table 23. Players Blood Plasma Fractionation Products Offered
Table 24. Blood Plasma Fractionation Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Blood Plasma Fractionation Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Blood Plasma Fractionation Sales Market Share Geographic Region (2019-2024)
Table 29. Global Blood Plasma Fractionation Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Blood Plasma Fractionation Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Blood Plasma Fractionation Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Blood Plasma Fractionation Sales Market Share by Country/Region (2019-2024)
Table 33. Global Blood Plasma Fractionation Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Blood Plasma Fractionation Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Blood Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 36. Americas Blood Plasma Fractionation Sales Market Share by Country (2019-2024)
Table 37. Americas Blood Plasma Fractionation Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Blood Plasma Fractionation Revenue Market Share by Country (2019-2024)
Table 39. Americas Blood Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 40. Americas Blood Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 41. APAC Blood Plasma Fractionation Sales by Region (2019-2024) & (K Units)
Table 42. APAC Blood Plasma Fractionation Sales Market Share by Region (2019-2024)
Table 43. APAC Blood Plasma Fractionation Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Blood Plasma Fractionation Revenue Market Share by Region (2019-2024)
Table 45. APAC Blood Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 46. APAC Blood Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 47. Europe Blood Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 48. Europe Blood Plasma Fractionation Sales Market Share by Country (2019-2024)
Table 49. Europe Blood Plasma Fractionation Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Blood Plasma Fractionation Revenue Market Share by Country (2019-2024)
Table 51. Europe Blood Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 52. Europe Blood Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Blood Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Blood Plasma Fractionation Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Blood Plasma Fractionation Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Blood Plasma Fractionation Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Blood Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Blood Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Blood Plasma Fractionation
Table 60. Key Market Challenges & Risks of Blood Plasma Fractionation
Table 61. Key Industry Trends of Blood Plasma Fractionation
Table 62. Blood Plasma Fractionation Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Blood Plasma Fractionation Distributors List
Table 65. Blood Plasma Fractionation Customer List
Table 66. Global Blood Plasma Fractionation Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Blood Plasma Fractionation Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Blood Plasma Fractionation Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Blood Plasma Fractionation Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Blood Plasma Fractionation Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Blood Plasma Fractionation Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Blood Plasma Fractionation Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Blood Plasma Fractionation Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Blood Plasma Fractionation Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Blood Plasma Fractionation Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Blood Plasma Fractionation Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Blood Plasma Fractionation Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Blood Plasma Fractionation Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Blood Plasma Fractionation Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Takeda Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 81. Takeda Blood Plasma Fractionation Product Portfolios and Specifications
Table 82. Takeda Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Takeda Main Business
Table 84. Takeda Latest Developments
Table 85. CSL Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 86. CSL Blood Plasma Fractionation Product Portfolios and Specifications
Table 87. CSL Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. CSL Main Business
Table 89. CSL Latest Developments
Table 90. Grifols Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 91. Grifols Blood Plasma Fractionation Product Portfolios and Specifications
Table 92. Grifols Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Grifols Main Business
Table 94. Grifols Latest Developments
Table 95. Octapharma Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 96. Octapharma Blood Plasma Fractionation Product Portfolios and Specifications
Table 97. Octapharma Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Octapharma Main Business
Table 99. Octapharma Latest Developments
Table 100. Kedrion Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 101. Kedrion Blood Plasma Fractionation Product Portfolios and Specifications
Table 102. Kedrion Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Kedrion Main Business
Table 104. Kedrion Latest Developments
Table 105. LFB Group Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 106. LFB Group Blood Plasma Fractionation Product Portfolios and Specifications
Table 107. LFB Group Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. LFB Group Main Business
Table 109. LFB Group Latest Developments
Table 110. Biotest Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 111. Biotest Blood Plasma Fractionation Product Portfolios and Specifications
Table 112. Biotest Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Biotest Main Business
Table 114. Biotest Latest Developments
Table 115. BPL Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 116. BPL Blood Plasma Fractionation Product Portfolios and Specifications
Table 117. BPL Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. BPL Main Business
Table 119. BPL Latest Developments
Table 120. RAAS Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 121. RAAS Blood Plasma Fractionation Product Portfolios and Specifications
Table 122. RAAS Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. RAAS Main Business
Table 124. RAAS Latest Developments
Table 125. CBPO Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 126. CBPO Blood Plasma Fractionation Product Portfolios and Specifications
Table 127. CBPO Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. CBPO Main Business
Table 129. CBPO Latest Developments
Table 130. Hualan Bio Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Bio Blood Plasma Fractionation Product Portfolios and Specifications
Table 132. Hualan Bio Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Hualan Bio Main Business
Table 134. Hualan Bio Latest Developments
Table 135. Tiantan Bio Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 136. Tiantan Bio Blood Plasma Fractionation Product Portfolios and Specifications
Table 137. Tiantan Bio Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Tiantan Bio Main Business
Table 139. Tiantan Bio Latest Developments
Table 140. Shuanglin Bio Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 141. Shuanglin Bio Blood Plasma Fractionation Product Portfolios and Specifications
Table 142. Shuanglin Bio Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Shuanglin Bio Main Business
Table 144. Shuanglin Bio Latest Developments
Table 145. Boya Bio Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 146. Boya Bio Blood Plasma Fractionation Product Portfolios and Specifications
Table 147. Boya Bio Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Boya Bio Main Business
Table 149. Boya Bio Latest Developments
Table 150. Yuanda Shuyang Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 151. Yuanda Shuyang Blood Plasma Fractionation Product Portfolios and Specifications
Table 152. Yuanda Shuyang Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Yuanda Shuyang Main Business
Table 154. Yuanda Shuyang Latest Developments
Table 155. Weiguang Bio Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 156. Weiguang Bio Blood Plasma Fractionation Product Portfolios and Specifications
Table 157. Weiguang Bio Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Weiguang Bio Main Business
Table 159. Weiguang Bio Latest Developments
Table 160. Nanyue Bio Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 161. Nanyue Bio Blood Plasma Fractionation Product Portfolios and Specifications
Table 162. Nanyue Bio Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Nanyue Bio Main Business
Table 164. Nanyue Bio Latest Developments
Table 165. KM Biologics Basic Information, Blood Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 166. KM Biologics Blood Plasma Fractionation Product Portfolios and Specifications
Table 167. KM Biologics Blood Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. KM Biologics Main Business
Table 169. KM Biologics Latest Developments
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization.png "Nikita Jabrela")
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (21 March, 2025)
- Notify To Team (21 March, 2025)
- Report updation (22 March, 2025)
- Report Quality Check (22 March, 2025)
- Report Dispatch (23 March, 2025)
- Hard Copy
Recently Viewed Products
Global Blood Plasma Fractionation Market Growth 2024-2030
We are friendly and approachable, give us a call.